Showing results (81-90 of 216) with videos related to
Sort By:
Pageof 22
Journal of Women'S Health (2002)|February 17, 2010
Identification of ovarian cancer symptoms in health insurance claims dataSean M Devlin, Paula H Diehr, M Robyn Andersen, et al.Leukemia Research|June 1, 2019
Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancerZachary D Epstein-Peterson, Sean M Devlin, Eytan M Stein, et al.Leukemia Research|May 22, 2012
Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromesVirginia M Klimek, Emily K Dolezal, Michael T Tees, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 16, 2019
Drugs as a Frequent Cause of Acute Rash in Patients after CD34+-Selected Peripheral Blood Stem Cell TransplantationSkylar Klager, Mario E Lacouture, Margaret Hannum, et al.Resuscitation|July 25, 2012
Regional variations in early and late survival after out-of-hospital cardiac arrestHenry E Wang, Sean M Devlin, Gena K Sears, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 25, 2020
Pretransplantation Cognitive Dysfunction in Advanced-Age Hematologic Cancers: Predictors and Associated OutcomesJames C Root, Claudine Campbell, Xiomara Rocha-Cadman, et al.Leukemia Research|February 7, 2018
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent dosesPatrick W Burke, Ibrahim Aldoss, Matthew A Lunning, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2014
Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantationCraig S Sauter, Lauren Lechner, Michael Scordo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
A phase I study of irinotecan as a 3-week schedule in children with refractory or recurrent solid tumorsGilles Vassal, Francois Doz, Didier Frappaz, et al.American Journal of Obstetrics and Gynecology|March 7, 2015
Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significanceSimon Mantha, Debra Sarasohn, Weining Ma, et al.Pageof 22